XML 59 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions (Additional Information) (Details) - USD ($)
 6 Months Ended
Jun. 14, 2022
May 31, 2022
May 12, 2022
Jun. 30, 2023
Dec. 31, 2022
Mar. 18, 2019
Business Acquisition [Line Items]            
Accrued Royalty Payables       $ 27,000    
Sorrento [Member]            
Business Acquisition [Line Items]            
Debt Instrument, Face Amount           $ 16,500,000
Patents [Member] | Sorrento [Member]            
Business Acquisition [Line Items]            
Payment upon the achievement of net sales   $ 20,000,000 $ 20,000,000      
Amount due for New Drug Application   $ 3,000,000 3,000,000      
2022 Promissory Note [Member] | Sorrento [Member]            
Business Acquisition [Line Items]            
Debt Instrument, Face Amount     5,000,000      
Notes Payable     $ 4,100,000      
Subordinated Borrowing, Interest Rate     2.66%      
License Agreement            
Business Acquisition [Line Items]            
Development milestones payment was recognized under other long-term liabilities       200,000 $ 200,000  
License Agreement | Romeg License Agreement [Member]            
Business Acquisition [Line Items]            
Up-front license fee $ 2,000,000          
Payment upon the achievement of net sales 13,000,000          
Payments for royalties 7,100,000          
Intangible asset 5,700,000          
Deferred consideration $ 3,700,000       3,700,000  
Contingent consideration, liability       $ 0 $ 0  
Intangible asset useful life 15 years